Russell E Ware

ORCID, self-asserted

ORCID 0000-0001-9582-0594

Publications

Citations

454

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

7 works in the graph, newest first.

Newborn screening results for sickle cell disease from the ASH Consortium on Newborn Screening in Africa (CONSA)
2026Blood AdvancesJournalOpen accessSenior authorCorresponding1 citations10.1182/bloodadvances.2026019796
Erythrocyte alloimmunization in children with sickle cell anemia living in Kilifi, Kenya
2025Blood Global HematologyJournalOpen access1 citations10.1016/j.bglo.2025.100016
Hydroxyurea for Children and Adults with Hemoglobin SC Disease
2024NEJM EvidenceJournalOpen accessSenior author19 citations10.1056/evidoa2400402
Baseline characteristics of Ghanaian children and adults enrolled in PIVOT , a randomised clinical trial of hydroxyurea in HbSC disease in sub‐Saharan Africa
2024British Journal of HaematologyJournalOpen accessSenior author5 citations10.1111/bjh.19832
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission
2023The Lancet HaematologyJournalOpen access171 citations10.1016/s2352-3026(23)00096-0
Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC disease
2023TrialsJournalOpen accessSenior author5 citations10.1186/s13063-023-07649-7
P-047: PROSPECTIVE IDENTIFICATION OF VARIABLES AS OUTCOMES FOR TREATMENT (PIVOT): A PHASE II CLINICAL TRIAL OF HYDROXYUREA FOR CHILDREN AND ADULTS WITH HBSC DISEASE
2022HemaSphereJournalOpen accessSenior author0 citations10.1097/01.hs9.0000873080.46800.92